US Stock MarketDetailed Quotes

RCKT Rocket Pharmaceuticals

Watchlist
  • 13.030
  • -0.010-0.08%
Trading Nov 21 15:50 ET
1.19BMarket Cap-4772P/E (TTM)

About Rocket Pharmaceuticals Company

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Company Profile

SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Gaurav Shah, M.D.
  • Director and Chief Executive Officer
  • 8.01M
  • Jonathan Schwartz, M.D.
  • Chief Medical Officer and Chief Gene Therapy Officer
  • 3.16M
  • Aaron Ondrey
  • Chief Financial Officer
  • --
  • Raj Prabhakar
  • Chief Business Officer and Senior Vice President
  • --
  • Mayo Pujols
  • Chief Technical Officer and Executive Vice President
  • 4.38M
  • Martin Wilson, J.D.
  • Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
  • --
  • Dr. Kinnari Patel, M.B.A.,Pharm.D.
  • President, Chief Operating Officer and Head of R&D
  • 4.85M
  • Mark White
  • General Manager, Commercial Affairs
  • --
  • John Militello, C.P.A.
  • Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
  • 1.53M
  • Dr. Roderick Wong, M.D.
  • Chairman of the Board
  • 409.99K
  • Dr. Mikael Dolsten, M.D.
  • Director
  • --
  • Pedro P. Granadillo
  • Independent Director
  • 429.98K
  • Robert Keith Woods
  • Independent Director
  • 568.70K
  • Dr. Fady Ibraham Malik, M.D.,PhD
  • Independent Director
  • 399.99K
  • Carsten Boess
  • Independent Director
  • 427.49K
  • Dr. Gotham Makker, M.D.
  • Independent Director
  • 399.99K
  • David P. Southwell
  • Independent Director
  • 399.99K
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 409.99K
  • Dr. Naveen Yalamanchi, M.D.
  • Independent Director
  • 417.49K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data